Effects of anchor structure and glycosylation of Fcγ receptor III on ligand binding affinity

Molecular Biology of the Cell

Volumn 27, Issue 22, 2016, Pages 3449-3458

  Jiang, Ning ^a,d,e   Chen, Wei ^b,e   Jothikumar, Prithiviraj ^a   Patel, Jaina M ^c   Shashidharamurthy, Rangaiah ^c,f   Selvaraj, Periasamy ^c   Zhu, Cheng ^a,b  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d The University of Texas at Austin   (United States)

^e SCHRÖDINGER INC   (United States)

^f PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; TUNICAMYCIN; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN G; ISOPROTEIN; LIGAND; PROTEIN BINDING;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; CELL ADHESION; CHO CELL LINE; CONTROLLED STUDY; DEGLYCOSYLATION; ERYTHROCYTE; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; STEREOSPECIFICITY; SURFACE PLASMON RESONANCE; ANIMAL; CELL MEMBRANE; GLYCOSYLATION; KINETICS; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL MEMBRANE; GLYCOSYLATION; GPI-LINKED PROTEINS; HUMANS; IMMUNOGLOBULIN G; KINETICS; LIGANDS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, IGG; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

EID: 84994619715     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E16-06-0470     Document Type: Article

References (59)

1. Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, Chen W, Levin AM, Connolly JM, Zhu C, et al. (2011). T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity 35, 681-693.
2. Barboni E, Rivero BP, George AJ, Martin SR, Renoup DV, Hounsell EF, Barber PC, Morris RJ (1995). The glycophosphatidylinositol anchor affects the conformation of Thy-1 protein. J Cell Sci 108, 487-497.
3. Case DA, Babin V, Berryman JT, Betz RM, Cai Q, Cerutti DS, Cheatham TE III, Darden TA, Duke RE, Gohlke H, et al. (2014). AMBER 14, San Francisco: University of California.
4. Chen W, Lou J, Evans EA, Zhu C (2012). Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells. J Cell Biol 199, 497-512.
5. Chen W, Lou J, Zhu C (2010). Forcing switch from short-To intermediate-And long-lived states of the alphaA domain generates LFA-1/ICAM-1 catch bonds. J Biol Chem 285, 35967-35978.
6. Chesla SE, Li P, Nagarajan S, Selvaraj P, Zhu C (2000). The membrane anchor influences ligand binding two-dimensional kinetic rates and three-dimensional affinity of FcgammaRIII (CD16). J Biol Chem 275, 10235-10246.
7. Chesla SE, Selvaraj P, Zhu C (1998). Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys J 75, 1553-1572.
8. Darden T, York D, Pedersen L (1993). Particle Mesh Ewald-An N.Log(N) method for Ewald sums in large systems. J Chem Phys 98, 10089-10092.
9. Dembo M, Torney DC, Saxman K, Hammer D (1988). The reaction-limited kinetics of membrane-To-surface adhesion and detachment. Proc R Soc Lond B Biol Sci 234, 55-83.
10. Drescher B, Witte T, Schmidt RE (2003). Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity. Immunology 110, 335-340.
11. Dumaswala UJ, Wilson MJ, Jose T, Daleke DL (1996). Glutamine-And phosphate-containing hypotonic storage media better maintain erythrocyte membrane physical properties. Blood 88, 697-704.
12. Edberg JC, Kimberly RP (1997). Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding. J Immunol 159, 3849-3857.
13. Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, et al. (2011). Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci USA 108, 12669-12674.
14. Fleit HB, Kobasiuk CD, Peress NS, Fleit SA (1992). A common epitope is recognized by monoclonal antibodies prepared against purified human neutrophil FcgRIII (CD16). Clin Immunol Immunopathol 62, 16-24.
15. Galon J, Robertson MW, Galinha A, Mazieres N, Spagnoli R, Fridman WH, Sautes C (1997). Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation. Eur J Immunol 27, 1928-1932.
16. Herr AB, Ballister ER, Bjorkman PJ (2003). Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423, 614-620.
17. Huang J, Zarnitsyna VI, Liu B, Edwards LJ, Jiang N, Evavold BD, Zhu C (2010). The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature 464, 932-936.
18. Humphrey W, Dalke A, Schulten K (1996). VMD: visual molecular dynamics. J Mol Graph 14, 33-38.
19. Huppa JB, Axmann M, Mortelmaier MA, Lillemeier BF, Newell EW, Brameshuber M, Klein LO, Schutz GJ, Davis MM (2010). TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463, 963-967.
20. Jiang N, Huang J, Edwards LJ, Liu B, Zhang Y, Beal CD, Evavold BD, Zhu C (2011). Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. Immunity 34, 13-23.
21. Kimberly RP, Ahlstrom JW, Click ME, Edberg JC (1990). The glycosyl phosphatidylinositol-linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII. J Exp Med 171, 1239-1255.
22. Kimberly RP, Wu J, Gibson AW, Su K, Qin H, Li X, Edberg JC (2002). Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity. Immunol Res 26, 177-189.
23. Kirschner KN, Yongye AB, Tschampel SM, Gonzalez-Outeirino J, Daniels CR, Foley BL, Woods RJ (2008). GLYCAM06: A generalizable biomolecular force field. Carbohydrates. J Comput Chem 29, 622-655.
24. Kong F, Garcia AJ, Mould AP, Humphries MJ, Zhu C (2009). Demonstration of catch bonds between an integrin and its ligand. J Cell Biol 185, 1275-1284.
25. Kukulansky T, Abramovitch S, Hollander N (1999). Cleavage of the glycosylphosphatidylinositol anchor affects the reactivity of thy-1 with antibodies. J Immunol 162, 5993-5997.
26. Lanier LL, Phillips JH, Testi R (1989). Membrane anchoring and spontaneous release of CD16 (FcR III) by natural killer cells and granulocytes. Eur J Immunol 19, 775-778.
27. Le Trong I, Aprikian P, Kidd BA, Forero-Shelton M, Tchesnokova V, Rajagopal P, Rodriguez V, Interlandi G, Klevit R, Vogel V, et al. (2010). Structural basis for mechanical force regulation of the adhesin FimH via finger trap-like beta sheet twisting. Cell 141, 645-655.
28. Li P, Jiang N, Nagarajan S, Wohlhueter R, Selvaraj P, Zhu C (2007). Affinity and kinetic analysis of Fcg receptor IIIa (CD16a) binding to IgG ligands. J Biol Chem 282, 6210-6221.
29. Li P, Nagarajan S, Zhu C, Selvaraj P (2002). Recombinant CD16A-Ig forms a homodimer and cross-blocks the ligand binding functions of neutrophil and monocyte Fcgamma receptors. Mol Immunol 38, 527-538.
30. Lou J, Yago T, Klopocki AG, Mehta P, Chen W, Zarnitsyna VI, Bovin NV, Zhu C, McEver RP (2006). Flow-enhanced adhesion regulated by a selectin interdomain hinge. J Cell Biol 174, 1107-1117.
31. Lou J, Zhu C (2007). A structure-based sliding-rebinding mechanism for catch bonds. Biophys J 92, 1471-1485.
32. Luo BH, Carman CV, Springer TA (2007). Structural basis of integrin regulation and signaling. Annu Rev Immunol 25, 619-647.
33. Maenaka K, van der Merwe PA, Stuart DI, Jones EY, Sondermann P (2001). The human low affinity Fc gamma receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J Biol Chem 276, 44898-44904.
34. Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015). ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11, 3696-3713.
35. Marshall BT, Long M, Piper JW, Yago T, McEver RP, Zhu C (2003). Direct observation of catch bonds involving cell-Adhesion molecules. Nature 423, 190-193.
36. Moody AM, North SJ, Reinhold B, Van Dyken SJ, Rogers ME, Panico M, Dell A, Morris HR, Marth JD, Reinherz EL (2003). Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem 278, 7240-7246.
37. Nagarajan S, Anderson M, Ahmed SN, Sell KW, Selvaraj P (1995a). Purification and optimization of functional reconstitution on the surface of leukemic cell lines of GPI-Anchored Fc gamma receptor III. J Immunol Methods 184, 241-251.
38. Nagarajan S, Chesla S, Cobern L, Anderson P, Zhu C, Selvaraj P (1995b). Ligand binding and phagocytosis by CD16 (Fc gamma receptor III) isoforms. Phagocytic signaling by associated zeta and gamma subunits in Chinese hamster ovary cells. J Biol Chem 270, 25762-25770.
39. Nimmerjahn F, Ravetch JV (2008). Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8, 34-47.
40. Nimmerjahn F, Ravetch JV (2010). Antibody-mediated modulation of immune responses. Immunol Rev 236, 265-275.
41. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K (2005). Scalable molecular dynamics with NAMD. J Comput Chem 26, 1781-1802.
42. Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD (2001). The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 276, 16469-16477.
43. Ravetch JV, Perussia B (1989). Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med 170, 481-497.
44. Ryckaert JP, Ciccotti G, Berendsen HJC (1977). Numerical-integration of cartesian equations of motion of a system with constraints-molecular-dynamics of N-Alkanes. J Comput Phys 23, 327-341.
45. Sabatino JJ Jr., Huang J, Zhu C, Evavold BD (2011). High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med 208, 81-90.
46. Selvaraj P, Carpen O, Hibbs ML, Springer TA (1989). Natural killer cell and granulocyte Fc gamma receptor III (CD16) differ in membrane anchor and signal transduction. J Immunol 143, 3283-3288.
47. Selvaraj P, Rosse WF, Silber R, Springer TA (1988). The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333, 565-567.
48. Shashidharamurthy R, Zhang F, Amano A, Kamat A, Panchanathan R, Ezekwudo D, Zhu C, Selvaraj P (2009). Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-Affinity Fc gamma receptor CD32A. J Immunol 183, 8216-8224.
49. Sondermann P, Huber R, Oosthuizen V, Jacob U (2000). The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406, 267-273.
50. Teillaud JL, Bouchard C, Astier A, Teillaud C, Tartour E, Michon J, Galinha A, Moncuit J, Mazieres N, Spagnoli R, et al. (1994). Natural and recombinant soluble low-Affinity Fc gamma R: detection, purification, and functional activities. Immunomethods 4, 48-64.
51. Towns J, Cockerill T, Dahan M, Foster I, Gaither K, Grimshaw A, Hazlewood V, Lathrop S, Lifka D, Peterson GD, et al. (2014). XSEDE: Accelerating scientific discovery. Comput Sci Eng 16, 62-74.
52. Unkeless JC, Shen Z, Lin CW, DeBeus E (1995). Function of human Fc gamma RIIA and Fc gamma RIIIB. Semin Immunol 7, 37-44.
53. Williams TE, Nagarajan S, Selvaraj P, Zhu C (2000a). Concurrent and independent binding of Fcgamma receptors IIa and IIIb to surface-bound IgG. Biophys J 79, 1867-1875.
54. Williams TE, Nagarajan S, Selvaraj P, Zhu C (2001). Quantifying the impact of membrane microtopology on effective two-dimensional affinity. J Biol Chem 276, 13283-13288.
55. Williams TE, Selvaraj P, Zhu C (2000b). Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2. Biophys J 79, 1858-1866.
56. Wu L, Xiao B, Jia X, Zhang Y, Lu S, Chen J, Long M (2007). Impact of carrier stiffness and microtopology on two-dimensional kinetics of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) interactions. J Biol Chem 282, 9846-9854.
57. Xiang X, Lee CY, Li T, Chen W, Lou J, Zhu C (2011). Structural basis and kinetics of force-induced conformational changes of an aA domain-containing integrin. PLoS One 6, e27946.
58. Xue J, Zhao Q, Zhu L, Zhang W (2010). Deglycosylation of FcalphaR at N58 increases its binding to IgA. Glycobiology 20, 905-915.
59. Yago T, Lou J, Wu T, Yang J, Miner JJ, Coburn L, Lopez JA, Cruz MA, Dong JF, McIntire LV, et al. (2008). Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 118, 3195-3207.